Deciphering the COVID‐19 cytokine storm: systematic review and meta‐analysis

R Mulchandani, T Lyngdoh… - European journal of …, 2021 - Wiley Online Library
Introduction The coronavirus pandemic has affected more than 20 million people so far.
Elevated cytokines and suppressed immune responses have been hypothesized to set off a …

[HTML][HTML] Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19

Y Liu, W Tan, H Chen, Y Zhu, L Wan, K Jiang… - BMC infectious …, 2021 - Springer
Background The lack of knowledge regarding the pathogenesis and host immune response
during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we …

[HTML][HTML] Analysis of inflammatory parameters and disease severity for 88 hospitalized COVID-19 patients in Wuhan, China

X Xu, MQ Yu, Q Shen, LZ Wang, RD Yan… - … journal of medical …, 2020 - ncbi.nlm.nih.gov
Background and aim: The outbreak of coronavirus disease 2019 (COVID-19) is quickly
turning into a pandemic. We aimed to further clarify the clinical characteristics and the …

[HTML][HTML] Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis

J Gorham, A Moreau, F Corazza, L Peluso… - PLoS …, 2020 - journals.plos.org
Introduction Coronavirus disease 2019 (COVID-19) appeared in China in December 2019
and has spread around the world. High Interleukin-6 (IL-6) levels in COVID-19 patients …

[PDF][PDF] Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.

Q Li, W Xu, WX Li, CL Huang… - European Review for …, 2020 - europeanreview.org
OBJECTIVE: We aimed to study the dynamics of cytokines and lymphocyte subsets and their
correlation with the prognosis of patients with severe COVID-19. PATIENTS AND …

[HTML][HTML] Differences of blood cells, lymphocyte subsets and cytokines in COVID-19 patients with different clinical stages: a network meta-analysis

W Yan, D Chen, FM Bigambo, H Wei, X Wang… - BMC infectious …, 2021 - Springer
Background Due to the rapid spread of coronavirus disease 2019 (COVID-19) worldwide, it
is necessary to ascertain essential immune inflammatory parameters that describe the …

Elevated levels of pleiotropic interleukin-6 (IL-6) and interleukin-10 (IL-10) are critically involved with the severity and mortality of COVID-19: an updated longitudinal …

S Jafrin, MA Aziz, MS Islam - Biomarker Insights, 2022 - journals.sagepub.com
Objectives: Disruption in the natural immune reaction due to SARS-CoV-2 infection can
initiate a potent cytokine storm among COVID-19 patients. An elevated level of IL-6 and IL …

[HTML][HTML] The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study

IY Hachim, MY Hachim, H Hannawi, KB Naeem… - PLoS …, 2021 - journals.plos.org
Several reports highlighted the central role of inflammation in the pathogenesis of corona
virus disease-19 (COVID-19) disease. Also, the hyper-inflammatory response that is …

Predicting disease severity and outcome in COVID-19 patients: a review of multiple biomarkers

Y Tjendra, AF Al Mana, AP Espejo… - … of pathology & …, 2020 - meridian.allenpress.com
Context.—An abundance of clinical reports focused on specific laboratory parameters have
been reported on coronavirus disease 19 (COVID-19), but a systematic analysis …

Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19

Y Ouyang, J Yin, W Wang, H Shi, Y Shi… - Clinical infectious …, 2020 - academic.oup.com
Abstract Background The World Health Organization characterizes novel coronavirus
disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome …